Buprenorphin-ratiopharm 70 Mikrogramm/h Transdermales Pflaster
Active ingredient: Buprenorphin
View notice details →News topic
Start: 2024-03
All current shortage notices related to Start: 2024-03, structured by product, country, active ingredient and reporting period.
7 noticesBuprenorphin-ratiopharm 52,5 Mikrogramm/h Transdermales Pflaster
Active ingredient: Buprenorphin
View notice details →Buprenorphin-ratiopharm 35 Mikrogramm/h Transdermales Pflaster
Active ingredient: Buprenorphin
View notice details →Buprenorphin AWD Matrix 70 Mikrogramm/h Transdermales Pflaster
Active ingredient: Buprenorphin
View notice details →Buprenorphin AWD Matrix 52,5 Mikrogramm/h Transdermales Pflaster
Active ingredient: Buprenorphin
View notice details →Daktarin 20 mg/g or. gel 40 g
Active ingredient: Miconazole
View notice details →Daktarin 20 mg/g or. gel 40 g
Active ingredient: Miconazole
View notice details →Plan supply. Connect sourcing and warehousing.
For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.
Improve sourcing and supply availability
Researching this shortage professionally? We assess sourcing routes, suppliers and cross-border supply against your requirements. A notice does not confirm stock availability.
Send a sourcing enquiry →Pharma warehouse and pharmaceutical warehousing in Cheb
Medicine storage, batch and expiry control, picking and distribution for Germany and Europe. We agree the storage profile, temperature and capacity with you.
Request warehouse capacity →